Evidence map›Paper›PMID 41283967›Full record

ReviewWorld journal of microbiology & biotechnology2025

Azospirillum spp. as bio-innovative defenders: Metabolomic signatures and molecular defense reprogramming in plant immunity against fungal phytopathogens.

Mohammad Shahid

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mohammad ShahidMarwadi University Research Centre, Department of Agriculture, Faculty of Science, Marwadi University, Rajkot, 360003, Gujrat, India. gd4858@myamu.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal diseases accounts for nearly 30-40% of global crop yield losses, underscoring the need for sustainable alternatives to chemical fungicides. Azospirillum spp., traditionally recognized for plant growth promotion, have emerged as potent biocontrol agent with multifaceted defense functions. Beyond niche competition and siderophore production, Azospirillum primes host immunity through reprogramming primary and secondary metabolism and activating systemic defense pathways such as salicylic acid (SA), jasmonic acid (JA), and induced systemic resistance (ISR). Metabolomic analyses reveal its influence on amino acids, sugars, phenolics, flavonoids, terpenoids, and phytohormones, while enhancing antioxidant systems. Integration of metabolomic and transcriptomic data identifies key regulatory genes and metabolites linked to fungal suppression. This review comprehensively summarizes molecular defense mechanisms, highlighting omics-based, and proposes metabolomics-guided applications of Azospirillum for sustainable and resilient crop protection.

Indexed as

AzospirillumPlant DiseasesPlant ImmunityPlantsCyclopentanesDisease ResistanceFungiMetabolomicsOxylipinsPlant Growth RegulatorsSalicylic AcidCyclopentanesjasmonic acidOxylipinsPlant Growth RegulatorsSalicylic AcidAzospirillumDefense responsesDisease suppressionMetabolitesSignaling pathwaysVolatile organic compounds

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.